Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T12:00:56.579Z.
Calculation as of: 2026-10-06T12:00:56.579Z.
Quote observation: 2026-10-05T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 237c69f2886ce95022375c2c4ca3b4be9bdf1b13d47079a179ac8fcd7ebd926e
EARNINGS YIELD
N/A
Allarity Therapeutics, Inc.
Market Cap
$15.91M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$15.30M
Earnings Yield
N/A
TTM Avg
0.79%
3Y Avg
0.79%
5Y Avg
0.82%
Market Cap
$16.54M
Earnings Yield
N/A
TTM Avg
119.21%
3Y Avg
119.21%
5Y Avg
80.35%
Market Cap
$14.28M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$13.34M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$18.77M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | $15.91M | N/A | N/A | N/A | N/A |
| BioCardia, Inc. (BCDA)vs › | $16.22M | N/A | 4.38% | 3.50% | 25.86% |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.30M | N/A | 0.79% | 0.79% | 0.82% |
| Dyadic International, Inc. (DYAI)vs › | $16.54M | N/A | 119.21% | 119.21% | 80.35% |
| Bionano Genomics, Inc. (BNGO)vs › | $16.58M | N/A | N/A | N/A | N/A |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $14.28M | N/A | N/A | N/A | N/A |
| Cellectar Biosciences, Inc. (CLRB)vs › | $13.34M | N/A | N/A | N/A | N/A |
| Estrella Immunopharma, Inc. (ESLA)vs › | $18.77M | N/A | N/A | N/A | N/A |
| Cosmos Health Inc. (COSM)vs › | $18.82M | N/A | 2.31% | 2.31% | 2.31% |
| Dare Bioscience, Inc. (DARE)vs › | $12.63M | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
